MedPath

To Asses efficacy and safety of polyherbal unani formulation In Nazla

Phase 2
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Registration Number
CTRI/2023/10/058727
Lead Sponsor
State Unani Medical College Himmatganj Prayagraj
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient of any sex

2. Age group between 19 to 50 years

3. Patients clinically diagnosed with Nazla Haar(Allergic Rhinitis).

4. Patients with raised Total Eosinophil Count and Total Serum IgE.

Exclusion Criteria

1. Age below 19 years and above 50 years.

2. Pregnancy and Lactation.

3. Patients with history of Comorbidities like Diabetes and Hypertension, Renal impairment, etc.

4.Patients with other disease of Nose.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath